Company Filing History:
Years Active: 2022-2023
Title: Derrick Houser: Innovator in Antibody Development
Introduction
Derrick Houser is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, his work focuses on innovative methods for treating various disorders, including cancer.
Latest Patents
Derrick's latest patents include the development of B7-H4 antibodies and methods of use thereof. These patents provide antibodies and antigen-binding fragments that specifically bind to human B7-H4, as well as to cynomolgus monkey, mouse, and rat B7-H4. The disclosed antibodies are designed to increase T cell proliferation, enhance interferon-gamma production, and deplete B7-H4 expressing cells through ADCC activity. Furthermore, these patents outline methods for treating disorders, such as cancer, by administering these specific antibodies.
Career Highlights
Derrick Houser is currently employed at Five Prime Therapeutics, Inc., where he continues to advance his research in antibody development. His work has positioned him as a key player in the biotechnology sector, contributing to innovative solutions for complex medical challenges.
Collaborations
Derrick collaborates with esteemed colleagues, including Charles Kaplan and Luis Borges. Their combined expertise fosters a productive environment for groundbreaking research and development.
Conclusion
Derrick Houser's contributions to the field of biotechnology, particularly through his patents on B7-H4 antibodies, highlight his role as an innovator in medical research. His work not only advances scientific understanding but also holds promise for future therapeutic applications.